Dual-Pathway Atrioventricular Nodal Electrophysiology

Dual-Pathway Atrioventricular Nodal Electrophysiology refers to the functional and anatomical presence of two distinct conduction pathways within the atrioventricular (AV) node, each with different electrophysiological properties. These dual pathways—commonly termed the fast and slow pathways—play a critical role in normal AV nodal conduction and are central to the pathophysiology of certain supraventricular tachyarrhythmias, particularly AV nodal reentrant tachycardia (AVNRT).

Anatomy and Functional Characteristics of the Dual Pathways

Fast Pathway

The fast pathway is located superiorly and posteriorly within the AV node region, near the apex of the triangle of Koch. It is characterized by relatively rapid conduction velocity and a longer effective refractory period. Because of its faster conduction, impulses traveling via the fast pathway reach the His bundle more quickly under normal conditions.

Slow Pathway

The slow pathway is situated inferiorly and anteriorly, near the coronary sinus ostium and the septal leaflet of the tricuspid valve. This pathway conducts impulses more slowly but has a shorter refractory period. The slow conduction velocity and shorter refractory period allow it to conduct impulses when the fast pathway is refractory, especially during premature atrial contractions.

Electrophysiological Properties and Mechanisms

Conduction Velocity and Refractoriness

The defining electrophysiological difference between the two pathways lies in their conduction velocities and refractory periods:

• The fast pathway conducts impulses rapidly but remains refractory for a longer duration after activation.
• The slow pathway conducts impulses slowly but recovers excitability more quickly.

These properties create a functional substrate for impulse conduction variations depending on the timing of atrial impulses.

Dual AV Nodal Physiology and Its Demonstration

Dual AV nodal physiology is identified during electrophysiological studies by the presence of a “jump” in the atrio-His (AH) interval during programmed atrial stimulation. When premature atrial stimuli (extrastimuli) are introduced progressively earlier in the cardiac cycle, conduction initially occurs via the fast pathway. However, if the fast pathway is refractory, conduction shifts to the slow pathway, increasing the AH interval abruptly. This phenomenon is termed an AH jump and is diagnostic of dual pathway physiology.

Role in Arrhythmogenesis: AV Nodal Reentrant Tachycardia (AVNRT)

Reentrant Circuit Formation

The dual pathways create the substrate for a reentrant circuit within or around the AV node. AVNRT typically involves:

• Antegrade conduction over the slow pathway (slow conduction velocity allows impulse delay)
• Retrograde conduction over the fast pathway (fast conduction velocity allows rapid return of the impulse)

This reentrant loop leads to rapid, repetitive activation of the AV node and consequent tachycardia, often manifesting as paroxysmal supraventricular tachycardia.

Types of AVNRT

The electrophysiological behavior of the pathways determines the type of AVNRT:

• Typical (slow-fast) AVNRT: Most common; antegrade conduction via the slow pathway, retrograde conduction via the fast pathway.
• Atypical AVNRT: Variants include fast-slow or slow-slow conduction patterns, depending on involvement and conduction direction in the pathways.

Clinical and Electrophysiological Implications

Diagnostic Techniques

Dual-pathway physiology is assessed through invasive electrophysiological studies involving programmed atrial stimulation to observe conduction properties and refractory periods. The hallmark AH jump and induction of AVNRT confirm the presence and functional significance of dual pathways.

Therapeutic Relevance

Understanding dual-pathway AV nodal electrophysiology guides therapeutic interventions:

• Catheter Ablation: Targeting the slow pathway is the preferred treatment for AVNRT, as it interrupts the reentrant circuit while preserving fast pathway conduction and normal AV nodal function.
• Pharmacological Therapy: Drugs influencing AV nodal conduction (e.g., calcium channel blockers, beta-blockers) modulate the conduction velocity and refractoriness of pathways, affecting arrhythmia initiation and maintenance.

Summary of Electrophysiological Parameters

Mathematical Model of Impulse Conduction Delay

Impulse conduction time (T) through a pathway is inversely related to conduction velocity (v) and proportional to the path length (L):

In dual-pathway physiology, the slow pathway has a lower conduction velocity (v_slow) than the fast pathway (v_fast), resulting in a longer conduction time (T_slow > T_fast) despite similar anatomical lengths.

Summary

Dual-Pathway Atrioventricular Nodal Electrophysiology encompasses the presence of two functionally distinct conduction pathways within the AV node, each with unique conduction velocities and refractory periods. This duality underlies normal AV conduction variability and provides the substrate for AV nodal reentrant arrhythmias. Its characterization is fundamental for diagnosis and targeted therapy of AVNRT and other related conduction abnormalities.